ProBio opens a 128,000-sq.-ft. gene therapy facility in Hopewell, creating 110+ jobs and advancing global cell and gene ...

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the potential.

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

Gene editing could be used to treat millions of glaucoma patients. Glaucoma is a leading cause of blindness, characterized by high pressure inside the eye. Patients often rely on daily eye drops to ...

Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular ...

Ferring USA in Parsippany employs more than 900 individuals. Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany June 17, 2025.

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

Corresponding author Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy talks ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today ...

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...